These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31622035)

  • 1. Cell therapy for central nervous system disorders: Current obstacles to progress.
    Yasuhara T; Kawauchi S; Kin K; Morimoto J; Kameda M; Sasaki T; Bonsack B; Kingsbury C; Tajiri N; Borlongan CV; Date I
    CNS Neurosci Ther; 2020 Jun; 26(6):595-602. PubMed ID: 31622035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stem cell therapy for ischemic stroke using iPS cells].
    Oki K
    Rinsho Shinkeigaku; 2013; 53(11):1017-9. PubMed ID: 24291865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cell therapy for Parkinson's disease with induced pluripotent stem cells].
    Morizane A
    Rinsho Shinkeigaku; 2019 Mar; 59(3):119-124. PubMed ID: 30814448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
    Chang KA; Lee JH; Suh YH
    J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regenerative therapy for post-stroke patients].
    Yamashita T; Abe K
    Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].
    Nakamura M; Toyama Y; Okano H
    Rinsho Shinkeigaku; 2013; 53(11):1013-5. PubMed ID: 24291863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retinal cell therapy using iPS cells].
    Takahashi M
    Rinsho Shinkeigaku; 2013; 53(11):1016. PubMed ID: 24291864
    [No Abstract]   [Full Text] [Related]  

  • 9. Neural Stem Cells and Human Induced Pluripotent Stem Cells to Model Rare CNS Diseases.
    De Filippis L; Zalfa C; Ferrari D
    CNS Neurol Disord Drug Targets; 2017; 16(8):915-926. PubMed ID: 28641519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in stem cell therapy for major human neurological disorders.
    Martínez-Morales PL; Revilla A; Ocaña I; González C; Sainz P; McGuire D; Liste I
    Stem Cell Rev Rep; 2013 Oct; 9(5):685-99. PubMed ID: 23681704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of iPS cells from patients with CNS diseases].
    Shimojima K; Yamamoto T
    No To Hattatsu; 2013 Mar; 45(2):137-42. PubMed ID: 23650819
    [No Abstract]   [Full Text] [Related]  

  • 12. Modeling human neurological disorders with induced pluripotent stem cells.
    Imaizumi Y; Okano H
    J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cells and neurological diseases.
    Hess DC; Borlongan CV
    Cell Prolif; 2008 Feb; 41 Suppl 1(Suppl 1):94-114. PubMed ID: 18181951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regeneration of the damaged central nervous system through reprogramming technology: basic concepts and potential application for cell replacement therapy.
    Matsui T; Akamatsu W; Nakamura M; Okano H
    Exp Neurol; 2014 Oct; 260():12-8. PubMed ID: 23036600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertain translation, uncertain benefit and uncertain risk: ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.
    Fung RK; Kerridge IH
    Bioethics; 2013 Feb; 27(2):89-96. PubMed ID: 21726264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell replacement therapy in neurological disease.
    Goldman SA; Windrem MS
    Philos Trans R Soc Lond B Biol Sci; 2006 Sep; 361(1473):1463-75. PubMed ID: 16939969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A challenge towards the clinical application of induced pluripotent stem cell technology for the treatment of Parkinson's disease].
    Morizane A; Takahashi J
    Brain Nerve; 2012 Jan; 64(1):29-37. PubMed ID: 22223499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
    Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell-based therapies in Parkinson's disease: future hope or current treatment option?
    Loewenbrück K; Storch A
    J Neurol; 2011 May; 258(Suppl 2):S346-53. PubMed ID: 21437664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments in intracerebral stem cell grafts.
    Reyes S; Tajiri N; Borlongan CV
    Expert Rev Neurother; 2015 Apr; 15(4):381-93. PubMed ID: 25739415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.